Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization

被引：0
|
作者：
Sebastian Kuger
Michael Flentje
Cholpon S. Djuzenova
机构：
[1] University Hospital of Würzburg,Department of Radiation Oncology
来源：
Radiation Oncology | / 10卷
关键词：
AZD6244; NVP-BEZ235; Radiosensitivity; Cell cycle arrest; Apoptosis; Autophagy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Co-targeting PIM and PI3K/mTOR pathways with a single molecule: Novel orally available combined PIM/PI3K and PIM/PI3K/mTOR kinase inhibitors.
    Blanco Aparicio, Carmen
    Renner, Oliver
    Gomez-Casero, Elena
    Cebria, Antonio
    Ajenjo, Nuria
    Aguirre, Enara
    Cebrian, David
    Rodriguez de Miguel, Ma Carmen
    Pequeno, Belen
    Isabel Albarran, Ma
    Riesco, Rosario
    Belen Garcia, Ana
    Alvarez, Rosa
    O'Neill, Michael
    Martinez, Sonia
    Pastor, Joaquin
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [22] PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair
    Xie, Yinghai
    Liu, Changwei
    Zhang, Yinci
    Li, Amin
    Sun, Chong
    Li, Rui
    Xing, Yingru
    Shi, Minghong
    Wang, Qi
    PLOS ONE, 2021, 16 (10):
  • [23] TARGETING THE PI3K/AKT/MTOR SIGNALING PATHWAYS IN CYSTIC FIBROSIS
    Reilly, R.
    Mroz, M.
    Dempsey, E.
    Shields, S.
    Wynne, K.
    McKone, E. F.
    Hiebel, C.
    Behl, C.
    Coppinger, J.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 200 - 200
  • [24] The Role of MAPK and PI3K/AKT/mTOR Signaling in Innate Lapatinib Resistance
    McDermott, M.
    O'Brien, N.
    McDonald, K.
    Crown, J.
    O'Donovan, N.
    Slamon, D.
    CANCER RESEARCH, 2011, 71
  • [25] NLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
    Rajendra Karki
    Si Ming Man
    R. K. Subbarao Malireddi
    Sannula Kesavardhana
    Qifan Zhu
    Amanda R. Burton
    Bhesh Raj Sharma
    Xiaopeng Qi
    Stephane Pelletier
    Peter Vogel
    Philip Rosenstiel
    Thirumala-Devi Kanneganti
    Nature, 2016, 540 : 583 - 587
  • [26] Irradiation and targeted inhibition of the PI3K/AKT and MAPK pathways in glioma
    Sminia, P.
    Narayan, R.
    Gasol, A.
    Cornelissen, F.
    Theys, J.
    Lagerwei, T.
    De Vries, E.
    Bikhezar, F.
    Denkova, A.
    De Kruijff, R.
    Slotman, B.
    Stalpers, L.
    Baumert, B.
    Westerman, B.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S345 - S346
  • [27] The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization
    Tothova, Zuzana
    Semelakova, Martina
    Solarova, Zuzana
    Tomc, Jana
    Debeljak, Natasa
    Solar, Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [28] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [29] TARGETING THE RAS/MAPK AND PI3K/MTOR SIGNALING PATHWAYS: A NEW APPROACH IN SENSITIVE AND RESISTANT CML CELL LINES?
    Alves, R.
    Fonseca, R.
    Goncalves, A.
    Alves, V.
    Sarmento-Ribeiro, A.
    HAEMATOLOGICA, 2012, 97 : 212 - 212
  • [30] The comparison between dual inhibition of mTOR with MAPK and PI3K signaling pathways in KRAS mutant NSCLC cell lines
    Turacli, Irem Dogan
    Ozkan, Ayla Cihan
    Ekmekci, Abdullah
    TUMOR BIOLOGY, 2015, 36 (12) : 9339 - 9345
12345